REMEGEN (09995): 193 million restricted shares will be listed for trading on July 1st.
Rongchang Biology (09995) announced that the stock listing type for this issue is initial restricted shares, and the stock subscription method is offline. The total number of shares listed is 193 million. The total number of shares listed in this issue is 193 million. The date of listing for this stock is July 1, 2026.
REMGEN (09995) announces that the stock listing type for this issue is initial restricted shares; the stock subscription method is offline, with a total of 193 million shares listed. The total number of shares listed in this stock listing is 193 million shares. The date of stock listing circulation for this issue is July 1, 2026.
As of the date of this announcement, due to the company's cash dividend not meeting the relevant regulations of the "Shanghai Stock Exchange Listed Company Self-Regulation Supervision Guidelines No. 15 - Shareholders, Directors, Senior Management Reduce Shareholding", shareholders whose restricted shares are to be released in this application may not reduce their holdings of the company's A shares through the stock exchange's centralized bidding trading or bulk trading.
Related Articles

Shenzhen Senior Technology Material (06067): Public offering in Hong Kong receives oversubscription of 1563.16 times.

Qingsong Health (02661) plans to buy back up to 1 billion Hong Kong dollars worth of company shares.

QINGSONG HEALTH (02661) Controlling shareholder Yang Yin voluntarily committed to extend the lock-up period.
Shenzhen Senior Technology Material (06067): Public offering in Hong Kong receives oversubscription of 1563.16 times.

Qingsong Health (02661) plans to buy back up to 1 billion Hong Kong dollars worth of company shares.

QINGSONG HEALTH (02661) Controlling shareholder Yang Yin voluntarily committed to extend the lock-up period.

RECOMMEND





